BioNTech
BNTX
#965
Rank
A$35.78 B
Marketcap
A$148.83
Share price
2.62%
Change (1 day)
-21.17%
Change (1 year)

Revenue for BioNTech (BNTX)

Revenue in 2025 (TTM): A$5.47 Billion

According to BioNTech's latest financial reports the company's current revenue (TTM ) is A$5.31 Billion. In 2024 the company made a revenue of A$4.76 Billion a decrease over the revenue in the year 2023 that were of A$6.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioNTech from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$5.47 B14.77%
2024 A$4.76 B-21.79%
2023 A$6.09 B-77.43%
2022 A$27.01 B-11.01%
2021 A$30.35 B3914.55%
2020 A$0.75 B336.63%
2019 A$0.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA